Accessibility: Skip TopNav
Swimmerplot
Patient response rates following treatment with CB-010, single dose at dose level 1, in the ANTLER Phase 1 trial
Format
PNG
Source
Caribou Biosciences, Inc.
Downloads
Original
Large
Medium
Small